The Upcoming PCAC Meeting The FDA notice confirms that the PCAC will convene this summer to evaluate whether to recommend the following seven bulk drug substances for inclusion on the 503A bulks list: July 23, 2026: BPC-157 (free base / acetate) KPV (free base / acetate) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) (free base / acetate) MOTs-C (free base / acetate) July 24, 2026: Emideltide (DSIP) (free base / acetate) Semax (free base / acetate) Epitalon (free base / acetate) All seven substances are of considerable interest to compounding pharmacies, prescribers, and patients
However, those with an unbalanced diet or without access to fresh fruits and vegetables may not
Knowing about them is vital for quick medical help
Tesamorelin and Ipamorelin Blend Product Description The Tesamorelin/Ipamorelin blend combines a synthetic GHRH analogue with a selective growth hormone secretagogue, designed for laboratory research investigating growth hormone regulation pathways
If you are new to copper peptides, our dedicated GHK-Cu guide covers the molecule in depth, and our overview of peptides for skin puts it in the broader context of cosmetic peptide science